Partner Headlines - EXEL

  1. Zoetis Tops Q3 Earnings Estimates, Updates Outlook

    TalkMarkets
  2. J&J Outshines in Q3 Earnings on Strong Pharma Sales

    TalkMarkets
  3. Will These 5 Drug Stocks Be Big Winners This Earnings Season?

    TalkMarkets
  4. Exelixis - Chart Of The Day - September 26, 2016

    TalkMarkets
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. 5 Stocks You Should Be Watching Today

    Benzinga
  7. The Best-Performing Non-S&P Stocks of 2015

    GuruFocus
  8. Top-Performing Non-S&P 500 Stocks of the Year

    GuruFocus
  9. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  10. Exelixis Announces Presentation of Positive Overall Survival ...

    Benzinga
  11. Morning Market Gainers

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. Exelixis Announces Positive Overall Survival Results from coBRIM ...

    Benzinga
  14. Morning Market Losers

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, ...

    Benzinga
  17. Morning Market Gainers

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Exelixis Prices 25M Share Offering @$5.40/Share

    Benzinga
  21. Benzinga's Top #PreMarket Losers

    Benzinga
  22. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD
  23. Bristol-Myers: kidney drug win

    IBD
  24. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold ...

    Benzinga
  25. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD
  26. Mid-Morning Market Update: Markets Mostly Flat; Morgan Stanley ...

    Benzinga
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Exelixis Announces Start of Phase 1 Trial of Cabozantinib in ...

    Benzinga
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. Watch These 10 Stocks Over The Weekend

    Benzinga
  31. Morning Market Gainers

    Benzinga
  32. Benzinga's Top #PreMarket Gainers

    Benzinga
  33. Morning Market Gainers

    Benzinga
  34. Benzinga's Top #PreMarket Gainers

    Benzinga
  35. Exelixis Data Release Upcoming; Options Activity Spiking

    Benzinga
  36. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  37. 5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic ...

    GuruFocus
  38. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion ...

    Benzinga
  39. Mid-Morning Market Update: Markets Open Lower; Weatherford To ...

    Benzinga
  40. Morning Market Losers

    Benzinga
  41. Events for the Week of Nov. 17-21, 2014

    Benzinga
  42. Morning Market Movers

    Benzinga
  43. 5-year lows: National Presto Industries, Ennis Inc, Landauer ...

    GuruFocus
  44. Stocks Hitting 52-Week Lows

    Benzinga
  45. Equities, Commodities & Bonds Finish Lower On First Trading Day ...

    Benzinga
  46. Midday Losers From Tuesday, September 2

    Benzinga
  47. Exelixis Shares Slide On Trial Results; Norwegian Cruise Line ...

    Benzinga
  48. Markets Mixed; Conn's Profit Misses Estimates

    Benzinga
  49. Stocks Hitting 52-Week Lows

    Benzinga
  50. Morning Market Losers

    Benzinga
  51. Benzinga's Top Downgrades

    Benzinga
  52. Stifel Nicolaus Downgrades Exelixis To Hold

    Benzinga
  53. Stocks To Watch For September 2, 2014

    Benzinga
  54. Exelixis Announces Results From COMET-1 Phase 3 Pivotal Trial ...

    Benzinga
  55. Mid-Afternoon Market Update: Harmonic Drops On Weak Forecast; ...

    Benzinga
  56. Harmonic Drops On Weak Forecast; URS Shares Surge

    Benzinga
  57. Mid-Morning Market Update: Markets Open Higher; Citigroup Profit ...

    Benzinga
  58. Morning Market Movers

    Benzinga
  59. Exelixis Shares Move 12% On Phase 3 Data

    Benzinga
  60. Benzinga's Top #PreMarket Gainers

    Benzinga
  61. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  62. Benzinga's Top #PreMarket Gainers

    Benzinga
  63. Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian ...

    GuruFocus
  64. Market Wrap For March 26: Markets Close Near Session Lows In ...

    Benzinga
  65. Mid-Afternoon Market Update: Markets Turn Red as Dish Network ...

    Benzinga
  66. Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis ...

    Benzinga
  67. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  68. Stocks Hitting 52-Week Lows

    Benzinga
  69. Morning Market Losers

    Benzinga
  70. Benzinga's Top #PreMarket Losers

    Benzinga
  71. Morning Market Movers

    Benzinga
  72. US Stock Futures Rise Ahead Of Housing Data

    Benzinga
  73. Exelixis Prices 10M Share Offering at $8 per Share

    Benzinga
  74. Oversold ETFs Looking Attractive (IHE, CSD, PSCE)

    Benzinga
  75. Exelixis Announces Promising Phase 1b Data for Cobimetinib in ...

    Benzinga
  76. US Stock Futures Rise Ahead Of Jobless Claims, GDP Data

    Benzinga
  77. Exelixis Announces Full Patient Enrollment for COMET-1 Phase ...

    Benzinga
  78. US Stock Futures Up After Upbeat China Data

    Benzinga
  79. Exelixis Initiates Phase 3 Clinical Trial of Cabozantinib

    Benzinga
  80. Exelixis Receives EMA Acceptance of Marketing Authorization App ...

    Benzinga
  81. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  82. Exel Presents Interim Data for Cabozantinib 40 mg Dose Cohort ...

    Benzinga
  83. First Solar, Sears Holdings Among Stocks Down on Above-average ...

    FoxBusiness
  84. Exelixis Says FDA Says NDA Has Been Removed from November Agenda

    Benzinga
  85. UPDATE: Piper Jaffray Reduces PT to $4.50 on Exelixis on Equity ...

    Benzinga
  86. Social Media Outlook for Thursday August 9 (EAT, NOV, NWSA, FSYS)

    Benzinga
  87. Exelixis, Universal Display Corporation Among Stocks Up on High ...

    FoxBusiness
  88. FDA's Oncologic Drugs Advisory Committee to Review Exelixis New ...

    Benzinga
  89. Exelixis (EXEL) Loses 8.8% As Company Sells Stock, Debt

    MarketIntelligenceCenter
  90. Health Care Sector Wrap

    FoxBusiness
  91. HCA Holdings, American Capital Mortgage Investment Crp Among ...

    FoxBusiness
  92. Interpublic Group, Exelixis Gapping Down Monday

    FoxBusiness
  93. UPDATE: Exelixis Announces Proposed Convertible Debt Offering ...

    Benzinga
  94. Exelixis Proposed Offering 20M Shares

    Benzinga
  95. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  96. Social Media Outlook for Monday July 30 (SHAW, BBY, EXEL, VHC)

    Benzinga
  97. Benzinga's Top Pre-Market Gainers

    Benzinga
  98. FDA Grants Priority Review for Cabozantinib in Medullary Thyroid ...

    Benzinga
  99. Exelixis Announces Initiation of Cabozantinib Investigator-Sponsored ...

    Benzinga
  100. Jefferies Reiterates Hold Rating, $6 PT for Exelixis

    Benzinga
Trading Center